Overview
Who this competition fits
Builders comfortable with Chinese algorithm-competition pages hosted by iFlytek.
Read the original official blurb
抗体药物偶联物（Antibody-Drug Conjugate, ADC）是近年来癌症靶向治疗领域的重要突破。简单来说，ADC就像一种“精准制导的导弹”，它通过抗体（一种能够识别特定目标的蛋白质）将细胞毒性药物（能够杀死癌细胞的化学物质）精准递送到肿瘤细胞中。与传统化疗药物相比，ADC的优势在于它能够降低药物对健康细胞的损害，同时提高对肿瘤细胞的杀伤效… Official track: 数据挖掘. Sponsor: 沈阳药科大学. Teams entered: 193.
Preparation
From registration to a first submission
- 01
Can read Chinese competition pages
- 02
Comfortable submitting a baseline
Before you commit: Task details, eligibility, and scoring rules live mainly on the official iFlytek page and change each season.
Source
How this page was assembled
Competition information is structured from the official page. Scores are platform estimates for decision support; official rules take precedence.
- Official competition page
- iFlytek Challenge
- Last checked
- Jun 11, 2025